Application 020152

Type
NDA
Sponsor
BRISTOL MYERS SQUIBB

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SERZONENEFAZODONE HYDROCHLORIDETABLET;ORAL50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002SERZONENEFAZODONE HYDROCHLORIDETABLET;ORAL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
003SERZONENEFAZODONE HYDROCHLORIDETABLET;ORAL150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004SERZONENEFAZODONE HYDROCHLORIDETABLET;ORAL200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
005SERZONENEFAZODONE HYDROCHLORIDETABLET;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
006SERZONENEFAZODONE HYDROCHLORIDETABLET;ORAL300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
41165SUPPL2007-07-06
41162SUPPL2007-07-06
44046ORIG2007-05-09
41163SUPPL2007-05-09
20488SUPPL2007-05-09
20487SUPPL2007-05-09
12260SUPPL2005-01-13
2092SUPPL2005-01-13
41164SUPPL2005-01-06
2091SUPPL2004-06-01
2089SUPPL2003-05-30
2090SUPPL2002-06-20
2088SUPPL2002-01-08
21220SUPPL2001-12-04
21219SUPPL2001-03-21
2087SUPPL1998-03-31
52060ORIG1900-01-01
52059ORIG1900-01-01
52058ORIG1900-01-01